Investor Relations

BHC:CC

Quote

Short

News

Articles

Message Board

Bausch Health Companies Inc. (TSXC : BHC:CC ) News

News Releases

BHC:CC News Releases

July 07, 2026 07:00:00 am

PR Newswire

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

July 06, 2026 07:00:00 am

Canada Newswire

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia

July 01, 2026 04:15:00 pm

PR Newswire

Michael Goettler Resigns from Bausch Health's Board of Directors

June 09, 2026 08:00:00 am

Canada Newswire

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia

June 02, 2026 12:13:27 pm

SeekingAlpha

Bausch Health: Invest In The Short-Term Bonds, Not The Stock

May 28, 2026 04:15:00 pm

PR Newswire

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

May 20, 2026 04:20:57 pm

SeekingAlpha

Bausch Health Companies Inc. (BHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

May 19, 2026 04:37:00 pm

Baystreet

High Rates Weigh on Stocks

May 19, 2026 04:15:00 pm

PR Newswire

Bausch Health Announces 2026 Annual Meeting of Shareholder Results

May 19, 2026 03:31:09 pm

SeekingAlpha

Bausch Health Companies Inc. (BHC) Presents at Barclays 30th Annual Leveraged Finance Conference 2026 Transcript

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account